-+ 0.00%
-+ 0.00%
-+ 0.00%

GENERATE BIOMEDICINES INC : MORGAN STANLEY INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $20

Reuters·03/24/2026 12:44:29

Please log in to view news